Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-04-000062
Filing Date
2004-06-02
Accepted
2004-06-02 10:51:23
Documents
1
Period of Report
2004-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3785
  Complete submission text file 0000875320-04-000062.txt   5446
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O PFIZER INC 235 EAST 42ND ST ATTN: CORPORATE SEC NEW YORK NY 10017 2127334802
NIBLACK JOHN F (Reporting) CIK: 0001174456 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 04843126